Table 2 Patient demographic data and serum CA 125 according to histological findings in the study
From: Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses
All patients | Statistic | Benign Tumor (n = 184) | Borderline/Malignant Tumor (n = 269) | Total | p |
|---|---|---|---|---|---|
Age (years) (Minimum-Maximum) | Mean ± SD | 45.02 ± 14.97 (18–78) | 51.30 ± 11.59 (12–81) | 48.75 ± 13.40 (12–81) | <0.001 |
Max lesion diameter, mm | Mean ± SD | 106.17 ± 68.01 (23–360) | 105.36 ± 63.03 (22–400) | 105.90 ± 64.03 (22–400) | >0.05 |
Location | No.(%) | Â | Â | Â | >0.05 |
left | Â | 92/229 (40.17) | 137/229 (59.82) | 229 | Â |
right | Â | 92/224 (41.07) | 132/224 (58.93) | 224 | Â |
CA125 (U/mL) | Median | 14 | 231 | 59 | Â |